Gold and silver nanoparticles conjugated with heparin derivative possess anti-angiogenesis properties

Nanotechnology

Volumn 20, Issue 45, 2009, Pages

  Kemp, Melissa M ^a   Kumar, Ashavani ^b   Mousa, Shaymaa ^c   Dyskin, Evgeny ^c   Yalcin, Murat ^c   Ajayan, Pulickel ^b   Linhardt, Robert J ^a,d   Mousa, Shaker A ^c  

^a RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^b Rice University   (United States)

^c ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^d Research Rensselaer Polytechnic Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; BASIC FIBROBLAST GROWTH FACTOR; BIOLOGICAL PROPERTIES; GLUCOSE-CONJUGATION; GOLD AND SILVER NANOPARTICLES; GOLD NANOPARTICLES; INFLAMMATORY DISEASE; METAL NANOPARTICLES; POTENTIAL EFFECTS; REDUCTANTS; SILVER NANOPARTICLES; SILVER NITRATES;

BIOPOLYMERS; CELL CULTURE; CHLORINE COMPOUNDS; GLUCOSE; GOLD; MEDICAL APPLICATIONS; NANOPARTICLES; ORGANIC POLYMERS; POLYSACCHARIDES;

SILVER;

FIBROBLAST GROWTH FACTOR; GOLD CHLORIDE; GOLD NANOPARTICLE; HEPARIN DERIVATIVE; NANOPARTICLE; SILVER; SILVER NITRATE; ANGIOGENESIS INHIBITOR; FIBROBLAST GROWTH FACTOR 2; GOLD; GOLD DERIVATIVE; HEPARIN; METAL NANOPARTICLE;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CHEMICAL ANALYSIS; CHEMICAL REACTION; CONTROLLED STUDY; PRIORITY JOURNAL; SYNTHESIS; ULTRAVIOLET SPECTROSCOPY; ANGIOGENESIS; ANIMAL; C57BL MOUSE; CHEMISTRY; CHICK EMBRYO; DRUG EFFECT; MALE; MOUSE; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANGIOGENESIS INHIBITORS; ANIMALS; CHICK EMBRYO; FIBROBLAST GROWTH FACTOR 2; GOLD; GOLD COMPOUNDS; HEPARIN; MALE; METAL NANOPARTICLES; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; NEOVASCULARIZATION, PHYSIOLOGIC; SILVER; SILVER NITRATE;

EID: 70350625081     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/20/45/455104     Document Type: Article

References (38)

1. Folkman J 1995 Angiogenesis in cancer, vascular, rheumatoid and other disease Nat. Med. 1 27-31
2. Carmeliet P 2005 Angiogenesis in life, disease and medicine Nature 438 932-6
3. Mousa S A 1996 Angiogenesis promoters and inhibitors: potential therapeutic implications Mol. Med. Today 2 140-2
4. Cross M J and Claesson-Welsh L 2001 FGF and VEGF function in angiogenesis: signaling pathways, biological responses and therapeutic inhibition Trends Pharmacol. Sci. 22 201-7
5. Folkman J, Weisz P B, Joullié M M, Li W W and Ewing W R 1989 Control of angiogenesis with synthetic heparin substitutes Science 243 1490-3
6. Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, Nagy J A, Atala A, Mukhopadhyay D and Soker S 2005 Antiangiogenic properties of gold nanoparticles Clin. Cancer Res. 11 3530-4
7. Cognet L, Tardin C, Boyer D, Choquet D, Tamarat P and Lounis B 2003 Single metallic nanoparticle imaging for protein detection in cells Proc. Natl Acad. Sci. USA 100 11350-5
8. Hirsch L R, Stafford R J, Bankson J A, Sershen S R, Rivera B, Price R E, Hazle J D, Halas N J and West J L 2003 Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance Proc. Natl Acad. Sci. USA 100 13549-54
9. Huang X, El-Sayed I H, Qian W and El-Sayed M A 2006 Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods J. Am. Chem. Soc. 128 2115-20
10. Li J, Wang X, Wang C, Chen B, Dai Y, Zhang R, Song M, Lv G and Fu D 2007 The enhancement effect of gold nanoparticles in drug delivery and as biomarkers of drug-resistant cancer cells ChemMedChem 2 374-8
11. O'Neal D P, Hirsch L R, Halas N J, Payne J D and West J L 2004 Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles Cancer Lett. 209 171-6
12. Skirtach A G, Dejugnat C, Braun D, Susha A S, Rogach A L, Parak W J, Moehwald H and Sukhorukov G B 2005 The role of metal nanoparticles in remote release of encapsulated materials Nano Lett. 5 1371-7
13. Shrivas K and Wu H-F 2008 Modified silver nanoparticle as a hydrophobic affinity probe for analysis of peptides and proteins in biological samples by using liquid-liquid microextraction coupled to AP-MALDI-Ion trap and MALDI-TOF mass spectrometry Anal. Chem. 80 2583-9
14. Lee J-S, Ulmann P A, Han M S and Mirkin C A 2008 A DNA-gold nanoparticle-based colorimetric competition assay for the detection of cysteine Nano Lett. 8 529-33
15. Pissuwan D, Valenzuela S M and Cortie M B 2006 Therapeutic possibilities of plasmonically heated gold nanoparticles Trends Biotechnol. 24 62-7
16. Gole A, Kumar A, Phadtare S, Mandale A B and Sastry M 2001 Glucose induced in situ reduction of chloroaurate ions entrapped in a fatty amine film: formation of gold nanoparticle-lipid composites PhysChemComm 4 92-5
17. Huang H and Yang X 2004 Synthesis of polysaccharide-stabilized gold and silver nanoparticles: a green method Carbohydr. Res. 339 2627-31
18. Raveendran P, Fu J and Wallen S L 2003 Completely green synthesis and stabilization of metal nanoparticles J. Am. Chem. Soc. 125 13940-1
19. Capila I and Linhardt R J 2002 Heparin-protein interactions Angew. Chem. Int. Edn 41 390-412
20. Conrad H E 1998 Heparin-Binding Proteins (San Diego, CA: Academic Press) p527
21. Linhardt R J and Toida T 1997 Heparin oligosaccharides: new analogs development and applications Carbohydr. Drug Des. 277-341
22. Mousa S A, Feng X, Xie J, Du Y, Hua Y, He H, O'Connor L and Linhardt R J 2006 Synthetic oligosaccharide stimulates and stabilizes angiogenesis: structure-function relationships and potential mechanisms J. Cardiovasc. Pharmacol. 48 6-13
23. Fareed J, Jeske W, Hoppensteadt D, Clarizio R and Walenga J M 1996 Are the available low-molecular-weight heparin preparations the same? Sem. Thromb. Hemost. 22 77-91
24. Kemp M M, Kumar A, Mousa SS, Park T-J, Ajayan P, Kubotera N, Mousa S A and Linhardt R J 2009 Synthesis of gold and silver nanoparticles stabilized with glycosaminoglycans having distinctive biological activities Biomacromolecules 10 589-95
25. Davis F B, Mousa S A, O'Connor L, Mohamed S, Lin H Y, Cao H J and Davis P J 2004 Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface Circ. Res. 94 1500-6
26. Ausprunk D H, Knighton D R and Folkman J 1975 Vascularization of normal and neoplastic tissues grafted to the chick chorioallantois. Role of host and preexisting graft blood vessels Am. J. Pathol. 79 597-628
27. Mousa S A, O'Connor L J, Davis F B and Davis P J 2006 Proangiogenesis action of the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated Endocrinology 147 1602-7
28. Mousa S A, O'Connor L, Bergh J J, Davis F B, Scanlan T S and Davis P J 2005 The proangiogenic action of thyroid hormone analogue GC-1 is initiated at an integrin J. Cardiovasc. Pharmacol. 46 356-60
29. Mousa S A et al 2008 Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor Angiogenesis 11 183-90
30. Mousa S A, Mohamed S, Wexler E J and Kerr J S 2005 Antiangiogenesis and anticancer efficacy of TA138, a novel alpha v beta 3 antagonist Anticancer Res. 25 197-206
31. Patra C R, Bhattacharya R, Patra S, Vlahakis N E, Gabashvili A, Koltypin Y, Gedanken A, Mukherjee P and Mukhopadhyay D 2008 Proangiogenic properties of europium(III) hydroxide nanorods Adv. Mater. 20 753-6
32. Nadkarni V D, Pervin A and Linhardt R J 1994 Directional immobilization of heparin onto beaded supports Anal. Biochem. 222 59-67
33. Bitter T and Muir H M 1962 A modified uronic acid carbazole reaction Anal. Biochem. 4 330-4
34. Leff D V, Brandt L and Heath J R 1996 Synthesis and characterization of hydrophobic, organically-soluble gold nanocrystals functionalized with primary amines Langmuir 12 4723-30
35. Kumar A, Joshi H, Pasricha R, Mandale A B and Sastry M 2003 Phase transfer of silver nanoparticles from aqueous to organic solutions using fatty amine molecules J. Colloid Interface Sci. 264 396-401
36. Mousa S A and Mohamed S 2004 Anti-angiogenic mechanisms and efficacy of the low molecular weight heparin, tinzaparin: anti-cancer efficacy Oncol. Rep. 12 683-8
37. Mousa S A and Mohamed S 2004 Inhibition of endothelial cell tube formation by the low molecular weight heparin, tinzaparin, is mediated by tissue factor pathway inhibitor Thromb. Haemost. 92 627-33
38. Norrby K and Sörbo J 1992 Heparin enhances angiogenesis by a systemic mode of action Int. J. Exp. Pathol. 73 147-55